Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Toxics 2014, 2(1), 35-49; doi:10.3390/toxics2010035
Article

Risk Mitigation Measures: An Important Aspect of the Environmental Risk Assessment of Pharmaceuticals

1,†
, 2,†
, 3
, 4
, 5,†
 and 1,†,*
Received: 13 December 2013; in revised form: 13 January 2014 / Accepted: 16 January 2014 / Published: 28 January 2014
(This article belongs to the Special Issue Risk Assessment of Environmental Contaminants)
View Full-Text   |   Download PDF [612 KB, uploaded 28 January 2014]   |   Browse Figure
Abstract: Within EU marketing authorization procedures of human and veterinary medicinal products (HMP and VMP), an environmental risk assessment (ERA) has to be performed. In the event that an unacceptable environmental risk is identified, risk mitigation measures (RMM) shall be applied in order to reduce environmental exposure to the pharmaceutical. Within the authorization procedures of HMP, no RMM have been applied so far, except for specific precautions for the disposal of the unused medicinal product or waste materials. For VMP, a limited number of RMM do exist. The aim of this study was to develop consistent and efficient RMM. Therefore, existing RMM were compiled from a summary of product characteristics of authorized pharmaceuticals, and new RMM were developed and evaluated. Based on the results, appropriate RMM were applied within the authorization procedures of medicinal products. For HMP, except for the existing precautions for disposal, no further reasonable measures could be developed. For VMP, two specific precautions for disposal and 17 specific precautions for use in animals were proposed as RMM.
Keywords: authorization; environmental risk assessment; medicinal products; risk mitigation authorization; environmental risk assessment; medicinal products; risk mitigation
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Liebig, M.; Floeter, C.; Hahn, T.; Koch, W.; Wenzel, A.; Römbke, J. Risk Mitigation Measures: An Important Aspect of the Environmental Risk Assessment of Pharmaceuticals. Toxics 2014, 2, 35-49.

AMA Style

Liebig M, Floeter C, Hahn T, Koch W, Wenzel A, Römbke J. Risk Mitigation Measures: An Important Aspect of the Environmental Risk Assessment of Pharmaceuticals. Toxics. 2014; 2(1):35-49.

Chicago/Turabian Style

Liebig, Markus; Floeter, Carolin; Hahn, Thorsten; Koch, Wolfgang; Wenzel, Andrea; Römbke, Jörg. 2014. "Risk Mitigation Measures: An Important Aspect of the Environmental Risk Assessment of Pharmaceuticals." Toxics 2, no. 1: 35-49.

Toxics EISSN 2305-6304 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert